Methyl 6-formyl-7,9-dihydroxy-8-methyl-4-oxo-4,10-dihydrophenazine-1-carboxylate, with the CAS number 101708-64-9, is a complex organic compound characterized by its phenazine core structure, which is notable for its biological activity and potential applications in medicinal chemistry. This compound features multiple functional groups, including a formyl group, hydroxyl groups, and a carboxylate ester, contributing to its reactivity and solubility properties. The presence of hydroxyl groups suggests potential for hydrogen bonding, which may enhance its interactions with biological targets. The methyl and formyl substituents can influence the compound's lipophilicity and overall stability. Additionally, the phenazine moiety is known for its redox properties, which may play a role in its biological mechanisms. Overall, this compound's unique structure and functional groups make it a subject of interest for further research, particularly in the fields of pharmaceuticals and organic synthesis.

PD 116152 is a new, highly substituted phenazine with antitumor activity was isolated from the culture broth of a Streptomyces sp. It is a novel phenazine antitumor antibiotic. The antibiotic is selectively active versus the bacterium Streptococcus pneumoniae (MIC less than 0.46 microgram/ml); the antitumor activity versus murine P388 leukemia is T/C 149.

methyl 6-formyl-7,9-dihydroxy-8-methyl-4-oxo-4,10-dihydrophenazine-1-carboxylate

101708-64-9: Methyl 6-formyl-7,9-dihydroxy-8-methyl-4-oxo-4,10-dihydrophenazine-1-carboxylate, with the CAS number 101708-64-9, is a complex organic compound characterized by its phenazine core structure, which is notable for its biological activity and potential applications in medicinal chemistry. This compound features multiple functional groups, including a formyl group, hydroxyl groups, and a carboxylate ester, contributing to its reactivity and solubility properties. The presence of hydroxyl groups suggests potential for hydrogen bonding, which may enhance its interactions with biological targets. The methyl and formyl substituents can influence the compound's lipophilicity and overall stability. Additionally, the phenazine moiety is known for its redox properties, which may play a role in its biological mechanisms. Overall, this compound's unique structure and functional groups make it a subject of interest for further research, particularly in the fields of pharmaceuticals and organic synthesis.

<p>PD 116152: phenazine from Streptomyces with antitumor effects on P388 leukemia (T/C 149) and potent against Streptococcus pneumoniae (MIC &lt; 0.46 µg/ml).</p>

CAS 101708-64-9

methyl 6-formyl-7,9-dihydroxy-8-methyl-4-oxo-4,10-dihydrophenazine-1-carboxylate

PD 116152

Ref: TM-T28311